Irva Hertz-Picciotto Selected Research

Developmental Disabilities (Developmental Disability)

10/2019	Metabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome.
1/2014	Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study.
3/2011	Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.
1/2011	Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.
11/2008	Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.
1/2008	Brief report: plasma leptin levels are elevated in autism: association with early onset phenotype?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irva Hertz-Picciotto Research Topics

Disease

48	Autistic Disorder (Autism) 06/2022 - 07/2006
31	Autism Spectrum Disorder 06/2022 - 11/2009
6	Developmental Disabilities (Developmental Disability) 10/2019 - 01/2008
6	Birth Weight (Birth Weights) 01/2019 - 09/2003
4	Bronchitis 02/2016 - 10/2007
4	Neoplasms (Cancer) 01/2016 - 09/2003
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 12/2010
3	Pre-Eclampsia (Preeclampsia) 06/2015 - 04/2004
2	Hypoxia (Hypoxemia) 01/2022 - 02/2015
2	Obesity 01/2022 - 01/2019
2	Asthma (Bronchial Asthma) 01/2022 - 09/2015
2	Gestational Weight Gain 01/2019 - 01/2015
2	Neurodevelopmental Disorders 04/2015 - 10/2014
2	Inflammation (Inflammations) 02/2015 - 02/2012
2	Spontaneous Abortion (Miscarriage) 01/2012 - 02/2007
1	Premature Birth (Birth, Premature) 01/2022
1	Pregnancy Complications 01/2022
1	Down Syndrome (Down's Syndrome) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Overweight 01/2019
1	Pediatric Obesity 01/2019
1	Maternal Obesity 01/2019
1	Tuberculosis (Tuberculoses) 01/2016
1	Genomic Instability 01/2016
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2016

Drug/Important Bio-Agent (IBA)

7	PesticidesIBA 01/2022 - 11/2006
7	Biological ProductsIBA 11/2020 - 07/2006
6	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2015
6	Folic Acid (Vitamin M)FDA LinkGeneric 06/2022 - 07/2012
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2007
5	MercuryIBA 01/2022 - 01/2010
4	phthalic acid (phthalate)IBA 01/2022 - 06/2015
4	Air Pollutants (Pollutants, Air)IBA 01/2022 - 09/2013
4	ORALIT (ORS)IBA 01/2020 - 07/2011
4	XenobioticsIBA 01/2019 - 07/2006
4	AutoantibodiesIBA 01/2017 - 03/2008
4	CytokinesIBA 01/2017 - 01/2008
4	Polychlorinated Biphenyls (PCBs)IBA 11/2014 - 09/2005
3	VitaminsIBA 06/2022 - 07/2011
3	PhenolsIBA 01/2022 - 12/2019
3	CarbonIBA 01/2021 - 07/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2007
3	Particulate MatterIBA 02/2016 - 01/2013
3	Mitochondrial DNA (mtDNA)IBA 01/2016 - 12/2010
3	Dichlorodiphenyl Dichloroethylene (DDE)IBA 01/2016 - 11/2012
3	Interleukin-17 (Interleukin 17)IBA 09/2015 - 01/2008
3	ArsenicIBA 11/2012 - 09/2003
3	Immunoglobulin G (IgG)IBA 07/2012 - 03/2008
3	AntibodiesIBA 03/2011 - 03/2008
2	ChemokinesIBA 01/2022 - 03/2011
2	hydrogen sulfite (bisulfite)IBA 01/2021 - 01/2016
2	Caffeine (No Doz)FDA LinkGeneric 01/2021 - 01/2012
2	FluorocarbonsIBA 01/2021 - 01/2020
2	Pyrethrins (Pyrethroids)FDA Link 01/2021 - 10/2014
2	ParabensIBA 01/2021 - 12/2019
2	AndrogensIBA 11/2020 - 01/2017
2	OrganophosphatesIBA 01/2018 - 10/2014
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 02/2016 - 09/2013
2	2,4,5,2',4',5'-hexachlorobiphenylIBA 01/2016 - 01/2015
2	AntioxidantsIBA 01/2016 - 05/2014
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2014 - 06/2013
2	SmokeIBA 09/2013 - 09/2003
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2013 - 10/2007
2	Interleukin-23 (Interleukin 23)IBA 11/2009 - 01/2008
2	Immunoglobulins (Immunoglobulin)IBA 03/2009 - 10/2008
2	Drinking WaterIBA 06/2006 - 09/2003
1	CadmiumIBA 01/2022
1	cyclo(Arg-Pro) (CI 4)IBA 01/2022
1	mono-isobutyl phthalateIBA 01/2022
1	MetalsIBA 01/2022
1	ManganeseIBA 01/2022
1	SeleniumIBA 01/2022
1	Pesticide Residues (Pesticide Residue)IBA 01/2022
1	monobutyl phthalateIBA 01/2022
1	Trace Elements (Biometals)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	triclocarbanIBA 01/2021
1	bis(4-hydroxyphenyl)sulfoneIBA 01/2021
1	bisphenol FIBA 01/2021
1	Triclosan (pHisoHex)FDA Link 01/2021
1	bisphenol AIBA 01/2021
1	ethyl-p-hydroxybenzoateIBA 01/2021
1	perfluorooctaneIBA 01/2020
1	perfluorooctanoic acidIBA 01/2020
1	Phenol (Carbolic Acid)FDA Link 12/2019
1	Endocrine DisruptorsIBA 12/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2019
1	ChromatinIBA 01/2019
1	VaccinesIBA 11/2018
1	OzoneIBA 09/2017
1	Dehydroepiandrosterone (DHEA)IBA 01/2017
1	Androstenedione (4 Androstene 3,17 dione)IBA 01/2017
1	IsotopesIBA 01/2017
1	Testosterone (Sustanon)FDA Link 01/2017
1	Soaps (Soap)IBA 12/2016
1	Interleukin-10 (Interleukin 10)IBA 02/2016
1	Dust (House Dust)FDA Link 06/2015

Therapy/Procedure

2	Complementary Therapies (Alternative Medicine) 11/2018 - 01/2014